Please login to the form below

Not currently logged in

Half of European cancer drug trials ‘biased’, says BMJ

BMJ logo

Report says studies exaggerate benefits

Breath test could predict cancer patient response to immunotherapy

A 3D image of someone's lungsStudy found device could predict response in lung cancer

Bluebird Bio reveals further encouraging data for CALD gene therapy

Bluebird BioStudy shows continued benefit in treatment of rare disease

Biogen loses another pipeline drug to toxicity concerns

BiogenFollows discontinuation of Eisai-partnered Alzheimer's drug

Novartis eyes potential new indication for Cosentyx

Novartis HQUnveils positive late-stage results in axial spondyloarthritis

Acceleron scraps rare muscular dystrophy drug

AcceleronClinical profile not strong enough to push into late-stage testing

New data backs GeNeuro’s MS drug after Servier exit

Brain scanSearch continues for new development partner

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Latest blow in string of failures for BACE inhibitor category

Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial

CelgeneRegulatory filings expected in first half of 2020

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...